Barry Wolfenson

CEO at Woundforce

Barry Wolfenson is senior executive with over 15 years of experience in the advanced wound care industry. He previously served as CEO of Sano, LLC, a medical diagnostics company focused on the early detection of inflammation in various disease states. Prior to that, he served as President of the Advanced Wound Care division within Derma Sciences, after having led the creation of that division. While at Derma Sciences he ran one of the largest drug development programs in the field of advanced wound care, was responsible for all business development activities of the division, and managed the sales, marketing, and clinical departments. He also served in a variety of roles at Bristol-Myers Squibb, and was a consultant at Andersen Consulting. Barry received an MBA at the University of Michigan, and a BS in Economics with a Pre-Med Concentration at Franklin & Marshall College.

Timeline

  • CEO

    Current role